Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of beta-nicotinamide mononucleotide or precursor thereof in preparation of medicines or health products for treating or alleviating respiratory disorders or diseases

A single nucleotide, breathing disorder technology, applied in the field of medicine

Active Publication Date: 2019-07-12
SICHUAN UNIV
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Currently, there is no β-nicotinamide mononucleotide (NMN) and β-nicotinamide riboside (Nicotinamide Riboside, NR) to treat or alleviate chronic obstructive pulmonary disease and treat or alleviate the symptoms caused by inhalable particles. Reports on lung diseases, especially the aging of lung macrophages

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of beta-nicotinamide mononucleotide or precursor thereof in preparation of medicines or health products for treating or alleviating respiratory disorders or diseases
  • Use of beta-nicotinamide mononucleotide or precursor thereof in preparation of medicines or health products for treating or alleviating respiratory disorders or diseases
  • Use of beta-nicotinamide mononucleotide or precursor thereof in preparation of medicines or health products for treating or alleviating respiratory disorders or diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] Example 1 Study on the therapeutic effect of NMN and NR on chronic obstructive pulmonary disease

[0076] (1) Establishment of mouse model of chronic obstructive pulmonary disease

[0077] Animals: 6-8 weeks, C57 mice;

[0078] Reagent: porcine pancreatic elastase solution PPE (USA, Sigma), diluted in sterile PBS;

[0079] method:

[0080] 1) Anesthetize the mouse (adding isoflurane at a rate between 1.5-2 L / min), remove it from the box and place it in a supine position on a ramp, carefully open its mouth and attach the rubber band to the upper incisors , to lift the rubber band from the nail.

[0081] 2) Using a small pair of tweezers, gently grasp the mouse's tongue, pull it out from the mouth by 0.5-1 cm, and drop the elastase solution (50 μL) on the distal end of the oropharynx, that is, behind the tongue.

[0082] 3) Hold the tongue with one hand and block the two nostrils with the other hand for 5-6 seconds. With the extension of the tongue and the blockage of...

Embodiment 2

[0135] Example 2 β-nicotinamide mononucleotide NMN and β-nicotinamide ribose NR reduce the aging of lung macrophages caused by carbon particles, etc.

[0136] (1) Extraction of C57BL / 6 macrophages

[0137] To extract C57BL / 6 alveolar macrophages, cut the ribs of the mouse thorax so that the lungs can fully expand, then separate the trachea, cut a small opening along the cricoid cartilage, insert a flattened 20ml empty needle into the trachea, and suck 1ml of physiological Inject saline into the trachea, fix the needle with a needle holder, withdraw, repeat twice, centrifuge at 1000 rpm, process for 5 minutes, wash once with DMEM, transfer to a culture dish, add DMEM (containing calf serum), and wait for 2 hours to adhere to the wall , the original medium was discarded, and the resulting adherent cells were alveolar macrophages. For the extraction of C57BL / 6 peritoneal macrophages, inject 10ml of normal saline into the peritoneal cavity of the mouse, massage the two sides of t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and in particular, relates to a use of beta-nicotinamide mononucleotide or a precursor thereof in preparation of medicines or health productsfor treating or alleviating respiratory disorders or diseases. The technical problem to be solved by the invention comprises that a new alternative scheme is provided for preparation of the medicinesor health products for treating or alleviating the respiratory disorders or diseases, and the technical scheme for solving the technical problem comprises that provided is the use of the beta-nicotinamide mononucleotide or the precursor thereof in preparation of the medicines or health products for treating or alleviating the respiratory disorders or diseases. The beta-nicotinamide mononucleotideor beta-nicotinamide riboside can effectively treat pulmonary diseases such as chronic obstructive pulmonary disease, can significantly alleviate the aging of pulmonary macrophages caused by inhalablegranules, and has a good application prospect.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to the use of β-nicotinamide mononucleotide or its precursor in the preparation of medicines or health products for treating or alleviating respiratory disorders or diseases. Background technique [0002] Nicotinamide nucleotide is also called β-nicotinamide mononucleotide (β-Nicotinamide Mononucleotide, β-NMN or NMN) or nicotinamide mononucleotide or nicotinamide nucleotide, etc. The molecular formula is as follows: [0003] [0004] β-nicotinamide mononucleotide (NMN) [0005] Nicotinamide nucleotide is an important product of the reaction regulated by nicotinamide phosphoribosyltransferase (NAMPT), a key intermediate in the synthesis of NAD+, and plays an important role in cellular energy metabolism. And β-nicotinamide riboside (Nicotinamide Riboside, NR) is a precursor of β-nicotinamide mononucleotide (NMN). [0006] [0007] β-nicotinamide riboside (NR) [...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/706A61P11/00A23L33/10
CPCA61K31/706A61P11/00A23L33/10A23V2002/00A23V2200/314A23V2250/30
Inventor 魏霞蔚魏于全
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com